How to Read Puff Count Labels on skew CBD Vapes | Correction of Past CBN Products and Safety Precautions

Corrected on 2026-10-20:We have retracted the 'recommended puffs per 1 day,' 'inhalation methods to boost effects,' and introductions of past CBN-blended models from the previous version. The original publication date is retained.

The 'approx. ◯ puffs' figure shown on CBD vape packaging or product pages is a cartridge-capacity estimate based on machine testing,and does not indicate a safe number of puffs per 1 day or a puff count that produces health effects.

Table of Contents for this article.

Relationship Between Catalog 'Puff Count' and Physical Condition / Safety
CBD, THC, and CBN Are Different Substances: Check the 2026 Regulations
4 Certificate of Analysis (COA) Checkpoints Before Purchase or Use
Why "Safe Because It Is CBD" or "Side-Effect-Free Because It Is Natural" Cannot Be Assumed

Relationship Between Catalog 'Puff Count' and Physical Condition / Safety

The puff count listed on disposable pens and cartridges varies greatly depending on the seconds per 1 puff, battery condition, and ambient temperature. Do not increase your puff frequency based on ideas such as 'I must use it up to the listed count' or 'the more I puff, the more I can relax.'

In addition, among older products and third-party cartridges, some models contained what became a designated substance on 2026-6-1:CBN (Cannabinol). Before continuing to use any device or cartridge on hand, always check the ingredient label and the lot-specific Certificate of Analysis (COA).

CBD, THC, and CBN Are Different Substances: Check the 2026 Regulations

CBD (cannabidiol), CBN (cannabinol), and Δ9-THC are distinct compounds treated differently under Japanese law. Product names or package labels such as "CBD Product" or "Hemp-Derived" alone cannot determine all contained ingredients or legal compliance.

CBN became a designated substance on 2026-6-1.The Ministry of Health, Labour and Welfare prohibits in principle the manufacture, import, sale, possession, and use of CBN-containing products. While procedural exceptions exist for medical and research uses, they do not permit general consumer purchase or use. Do not rely on older reviews or past articles claiming "legal" or "recommended." Source:Ministry of Health, Labour and Welfare: Designation of CBN and ProceduresThe following is a list of the most common problems with the

In addition, category-specific residual limits for Δ9-THC took effect on 2024-12-12, and any product exceeding the threshold is classified as a narcotic. These figures are product concentration standards, not intake guidelines.

Product Category	Residual Limit for Δ9-THC
Oils and fats (liquid at room temperature) and powders	10ppm
Aqueous solutions	0.10ppm
All other products (confectionery, solids, VAPE liquids, etc.)	1ppm

Product appearance or naming alone does not determine whether an item falls under the oils/fats category. You must verify the actual product category against a lot-specific Certificate of Analysis (COA). Source:Ministry of Health, Labour and Welfare: Legal Amendments and Residual LimitsThe following is a list of the most common problems with the

4 Certificate of Analysis (COA) Checkpoints Before Purchase or Use

Match Between Product Name and Batch / Lot Number:Whether the lot number printed on your actual container matches the lot number on the report rather than a generic sample certificate.
Testing Laboratory and Analysis Date:Whether the name of the third-party laboratory, date of testing, and analytical method are clearly stated.
Limit of Quantification (LOQ) and Limit of Detection (LOD) for Δ9-THC:Whether testing sensitivity is below Japan's category-specific residual limits (10ppm / 0.10ppm / 1ppm), rather than merely stating "ND (Not Detected)."
Absence of Designated Substances (Such as CBN) and Undeclared Ingredients:Whether CBN, a designated substance since 2026-6-1, is confirmed absent.

Avoid using products without verifiable lot numbers or items from unverified sources such as social media or flea-market apps, as actual contents may differ from the label.

Why "Safe Because It Is CBD" or "Side-Effect-Free Because It Is Natural" Cannot Be Assumed

The U.S. FDA highlights risks associated with CBD including liver injury, interactions with concurrent medications, pronounced drowsiness, diarrhea, and appetite changes, while noting scientific unknowns regarding long-term use and differences across intake routes (inhalation, oral, topical). Source:FDA: Risks and Unknowns of CBD ProductsThe following is a list of the most common problems with the

Research on specific prescription CBD formulations cannot be treated as proof that commercial CBD oils, gummies, or VAPE liquids improve insomnia, relieve stress, boost immunity, or aid smoking cessation. Discontinue use immediately and consult a medical professional if you feel unwell. Anyone with preexisting conditions or taking medication should consult a physician or pharmacist rather than self-medicating.